Journal: Experimental and Therapeutic Medicine

Article Title: A prospective study on hyperhomocysteinemia as an aggravating factor in chronic venous insufficiency

doi: 10.3892/etm.2022.11376

Figure Lengend Snippet: Associations between homocysteine levels and the different parameters assessed in the study.

Article Snippet: High-performance liquid chromatography (HPLC) Homocysteine levels were determined using HPLC and a Homocysteine in Serum/Plasma HPLC kit (cat. no. 45000; Chromsystems Diagnostics).

Techniques: Coagulation

Journal: Experimental and Therapeutic Medicine

Article Title: A prospective study on hyperhomocysteinemia as an aggravating factor in chronic venous insufficiency

doi: 10.3892/etm.2022.11376

Figure Lengend Snippet: Plasmatic homocysteine levels (using HPLC) in the study group showing that 54.21% of the cases had increased values. HPLC, high-performance liquid chromatography.

Article Snippet: High-performance liquid chromatography (HPLC) Homocysteine levels were determined using HPLC and a Homocysteine in Serum/Plasma HPLC kit (cat. no. 45000; Chromsystems Diagnostics).

Techniques: High Performance Liquid Chromatography

Journal: Experimental and Therapeutic Medicine

Article Title: A prospective study on hyperhomocysteinemia as an aggravating factor in chronic venous insufficiency

doi: 10.3892/etm.2022.11376

Figure Lengend Snippet: Mean ± SD homocysteine levels in the study group, associated with the diagnosis of CVI, disease age, personal thrombosis history and obesity.

Article Snippet: High-performance liquid chromatography (HPLC) Homocysteine levels were determined using HPLC and a Homocysteine in Serum/Plasma HPLC kit (cat. no. 45000; Chromsystems Diagnostics).

Techniques: Standard Deviation

Journal:

Article Title: Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study

doi: 10.1111/j.1753-0407.2010.00070.x

Figure Lengend Snippet: Summary statistics comparing 2003–2004 and 2007–2008 HbA1c measurements ( n = 383 pairs)

Article Snippet: With alignment of all ARIC HbA1c values to the 2003–2004 measurements obtained on the Tosoh 2.2 instrument, the prevalence of undiagnosed diabetes (HbA1c ≥6.5%) was 2.7%.

Techniques:

Journal:

Article Title: Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study

doi: 10.1111/j.1753-0407.2010.00070.x

Figure Lengend Snippet: Comparison of 2003–2004 and 2007–2008 HbA1c (%) measurements performed using the Tosoh 2.2 and Tosoh G7 HPLC instruments (Tosoh Bioscience, South San Francisco, CA, USA), respectively (n = 383).

Article Snippet: With alignment of all ARIC HbA1c values to the 2003–2004 measurements obtained on the Tosoh 2.2 instrument, the prevalence of undiagnosed diabetes (HbA1c ≥6.5%) was 2.7%.

Techniques:

Journal:

Article Title: Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study

doi: 10.1111/j.1753-0407.2010.00070.x

Figure Lengend Snippet: Bland-Altman plot of the difference in HbA1c (%) between values determined using the Tosoh G7 (Tosoh Bioscience, South San Francisco, CA, USA) minus those obtained using the Tosoh 2.2 compared against the mean. The solid line is the zero (reference) line, whereas the dashed lines represent the mean and ±1.96SD.

Article Snippet: With alignment of all ARIC HbA1c values to the 2003–2004 measurements obtained on the Tosoh 2.2 instrument, the prevalence of undiagnosed diabetes (HbA1c ≥6.5%) was 2.7%.

Techniques: